---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-024035"
form_type: "8-K"
ticker: "GLSI"
cik: "0001799788"
company_name: "Greenwich LifeSciences, Inc."
filed_at: "2024-06-17T23:59:59+00:00"
generated_at: "2026-06-01T04:09:03.713446+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Greenwich LifeSciences raises ~$2.5M in private placement with CEO at $14.30/share

## Summary
- CEO Snehal Patel purchased 174,825 shares at $14.30 (June 12 closing price) for ~$2.5M gross proceeds.
- Shares are restricted securities, no registration rights; closing expected June 18, 2024.
- Net proceeds to be used for clinical development and working capital.
- Private placement is exempt under Section 4(a)(2) and Rule 506 of Securities Act.

## SEC filing metadata
- accession: 0001493152-24-024035
- form_type: 8-K
- ticker: GLSI
- cik: 0001799788
- company_name: Greenwich LifeSciences, Inc.
- filed_at: 2024-06-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799788/000149315224024035/0001493152-24-024035-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799788/000149315224024035/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-024035
- JSON: https://secwatch.observer/filing/0001493152-24-024035.json
- Plain text: https://secwatch.observer/filing/0001493152-24-024035.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.